Month: August 2022

Aug 11 2022

Uncategorized

Researchers study schizophrenia by emulating it in a petri dish

by Clinical Editor

No Comments

The team’s research results so far, recently chronicled in the journal Nature Communications, stand a chance of helping the field of psychiatry medicine out of its long slump, the researchers...

Aug 11 2022

Uncategorized

The Importance of Sexual Health in People with Schizophrenia

by Clinical Editor

No Comments

Cultural myth leads us to believe the sexual health of patients with schizophrenia is unimportant. Data show the contrary is true, given the high rates of STI and sexual dysfunction....

Aug 11 2022

Uncategorized

Karuna’s experimental schizophrenia drug succeeds in advanced study

by Clinical Editor

No Comments

If approved by the FDA, the Boston biotech’s medicine would be the first new type of treatment for the disease in decades.

Aug 11 2022

Uncategorized

Positive trial results for schizophrenia drug, KarTX, from PureTech’s founded entity, Karuna Therapeutics

by Clinical Editor

No Comments

Topline results from a phase 3 trial looking at the effect of a drug to treat schizophrenia were announced today (August 8).

Aug 10 2022

Uncategorized

Researchers study schizophrenia by emulating it in a petri dish

by Clinical Editor

No Comments

The team’s research results so far, recently chronicled in the journal Nature Communications, stand a chance of helping the field of psychiatry medicine out of its long slump, the researchers...

Aug 10 2022

Uncategorized

Karuna’s experimental schizophrenia drug succeeds in advanced study

by Clinical Editor

No Comments

If approved by the FDA, the Boston biotech’s medicine would be the first new type of treatment for the disease in decades.

Aug 10 2022

Uncategorized

The Importance of Sexual Health in People with Schizophrenia

by Clinical Editor

No Comments

Cultural myth leads us to believe the sexual health of patients with schizophrenia is unimportant. Data show the contrary is true, given the high rates of STI and sexual dysfunction....

Aug 10 2022

Uncategorized

Positive trial results for schizophrenia drug, KarTX, from PureTech’s founded entity, Karuna Therapeutics

by Clinical Editor

No Comments

Topline results from a phase 3 trial looking at the effect of a drug to treat schizophrenia were announced today (August 8).

Aug 10 2022

Uncategorized

Karuna’s Schizophrenia-Trial Data Are ‘Best Case Scenario’ for the Biotech Stock

by Clinical Editor

No Comments

New data from Karuna Therapeutics on the schizophrenia treatment KarXT sent shares of the biotech up more than 60% as analysts said the results were strong enough that the drug...

Aug 09 2022

Uncategorized

Researchers study schizophrenia by emulating it in a petri dish

by Clinical Editor

No Comments

The team’s research results so far, recently chronicled in the journal Nature Communications, stand a chance of helping the field of psychiatry medicine out of its long slump, the researchers...